Global Central Venous Catheter Market

Global Central Venous Catheter Market Size Insights Forecasts to 2035

• The Global Central Venous Catheter Market Size Was Estimated at USD 2.90 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.27 % from 2025 to 2035
• The Worldwide Central Venous Catheter Market Size is Expected to Reach USD 5.66 Billion by 2035
• North America is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, The Global Central Venous Catheter Market Size Was Worth Around USD 2.90 Billion In 2024 And Is Predicted To Grow To Around USD 5.66 Billion By 2035 With A Compound Annual Growth Rate (CAGR) Of 6.27 % From 2025 To 2035. The market for central venous catheters is expanding due to the rising incidence of chronic illnesses, the growth in critical care procedures, and the growing need for cutting-edge medical solutions. The central venous catheter market is seeing an increase in the use of minimally invasive procedures. These methods are becoming more and more popular among healthcare professionals because of their benefits, which include shorter recovery times and fewer complications.

 

Market Overview

The Central Venous Catheter Market Size is the healthcare segment around the globe that is focused on the devices intended for catheter insertion in one of the large veins, usually the subclavian, jugular, or femoral, to deliver medications, fluids, blood products, and nutrition, or to monitor the central venous pressure. Central venous catheters (CVCs) are one of the most important medical devices that allow medical staff to give fluids, medicines, and nutrients, and to monitor or take blood for tests. Such catheters play a key role, especially for cancer patients, those suffering from kidney diseases and patients who are on long-term intravenous therapies. The main factors contributing to the growth of the CVC market are the rising occurrence of chronic diseases, an increase in the number of surgical procedures, and the development of CVC products that facilitate safer use and therefore significantly decrease healthcare-associated infections. The quicker pace of innovations in the field of healthcare has resulted in the development of high-quality catheter materials and designs, thus enabling safety enhancements and infection risk reductions. This has further led to CVCs gaining the status of being highly necessary devices in intensive care and/or hospital settings.

 

Report Coverage

This research report categorises the Central Venous Catheter Market Size based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the central venous catheter market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the central venous catheter market. 

    

Driving Factors  

The Central Venous Catheter Market Size is witnessing significant changes now, mainly due to tech progress and the increasing need for less invasive surgeries. As chronic illnesses continue to spread, the demand for proper vascular access solutions has led to the development of new catheter designs and materials. Additionally, with the increasing knowledge of the benefits central venous catheters bring in critical care settings, the dynamics of the market are being impacted. Medical facilities are turning to these devices more and more in order to improve patient outcomes and make the treatment process easier. Also, regulatory agencies keeping an eye on safety and effectiveness standards have been forcing manufacturers to comply with strict rules. The demand for specialised medical devices that can help manage critically ill patients in intensive care units is on the rise. Innovations in catheter materials and infection prevention strategies are enabling the broad acceptance of the same. The ageing population and the prevalence of multiple health conditions are acting as key drivers of the market. Furthermore, increased healthcare expenditure and worldwide developments in medical infrastructure are paving the way for market growth.

 

Restraining Factors  

High risks of infection and thrombosis, complex regulatory criteria for product approval, and the availability of alternative, less invasive treatment options that prevent widespread adoption all pose challenges to the central venous catheter industry.

 

Market Segmentation    

The central venous catheter market share is classified into product type, property, and composition.     

 

• The tunnelled catheters segment accounted for the largest market share in 2024 and is projected to grow at a substantial CAGR over the forecast period.        

Based on the product type, the central venous catheter market is differentiated into non-tunnelled catheters and tunnelled catheters. Among these, the tunnelled catheters segment accounted for the largest market share in 2024 and is projected to grow at a substantial CAGR over the forecast period.

This segment expansion is attributed to their greater patient comfort and lower risk of complications if used for a long time. Moreover, this is because of their advantage for individuals needing long-term vascular access, e.g., patients on chemotherapy or hemodialysis. They result in lower infection risk and higher comfort level, thus making it possible to give medication over longer periods.

 

• The antimicrobial catheters segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.       

Based on the property, the central venous catheter market is segmented into non-antimicrobial catheters, antimicrobial catheters, and others. Among these, the antimicrobial catheters segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. This is due to their capacity to considerably lower the incidence of catheter-related infections, which is a major worry for medical professionals. Their market position is strengthened by their growing popularity in critical care environments. dominating the market as a result of their improved capacity to prevent infections.

 

• The polyurethane segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.      

Based on the composition, the central venous catheter market is divided into polyurethane, silicone, and others. Among these, the polyurethane segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. This includes resilience to kinking, strength, and flexibility. For long-term deployments and high-pressure applications, this makes them especially appropriate. Its long lifespan, which reduces the need for replacements and guarantees continuing efficacy, makes polyurethane frequently preferred by healthcare providers.

Regional Segment Analysis of the Central Venous Catheter Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

Asia Pacific is anticipated to hold the largest share of the central venous catheter market over the predicted timeframe.     

Asia Pacific is anticipated to hold the largest share of the central venous catheter market over the predicted timeframe. Asia-Pacific is the fastest-growing region in the central venous catheter market due to the increasing healthcare expenditure and the rising number of chronic diseases in the region. The region accounts for a substantial portion of the global market share, with China and India being the frontrunners. There is a rising demand for advanced medical technologies, which is being supported by government initiatives for the development of healthcare infrastructure.

 

China is the largest market in the region with considerable healthcare investments and an increasing number of hospitals. India is next, with a growing healthcare sector and rising awareness of advanced medical devices. The competitive landscape is a mixture of local and international players, thus driving innovation and market accessibility.

 

North America is expected to grow at a rapid CAGR in the central venous catheter market during the forecast period. The region is experiencing substantial development owing to the presence of well-established healthcare facilities, the increasing incidence of chronic diseases, and a higher number of surgical operations. Regulatory support through the FDA and other similar agencies further acts as a growth lever for the market by ensuring the safety and effectiveness of medical devices.

 

The United States is the main source of growth, where significant players such as Bard Medical, Medtronic, and Boston Scientific dominate the competition. The existence of these well, known companies encourages innovation and improves product supply. Canada, with its emphasis on elevating healthcare delivery and patient outcomes, fiercely complements the market growth.

 

Competitive Analysis:   

The report offers the appropriate analysis of the key organizations/companies involved within the central venous catheter market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.  

 

List of Key Companies

• AngioDynamics, Inc.
• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Cook Group
• Fresenius Medical Care AG & Co. KGaA
• KIMAL PLC
• Lepu Medical Technology (Beijing) Co., Ltd. (Comed B.V.)
• Medical Components, Inc.
• Medtronic Plc.
• Merit Medical Systems, Inc.
• Smiths Medical (ICU Medical Inc.)
• Teleflex Incorporated
• Vygon S.A.
• Others  

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

 

Recent Development

 

• In January 2025, Teleflex Incorporated was awarded a contract by Vizient, Inc., effective to supply its market-leading Arrow short-term central venous catheters (CVCs) and arterial catheters to Vizient’s extensive network of healthcare providers. This agreement strengthens Teleflex’s presence in the U.S. vascular access market and expands access to its products across more than 65% of the nation’s acute care providers.

 

Market Segment  

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the central venous catheter market based on the below-mentioned segments: 

  

Global Central Venous Catheter Market, By Product Type

• Non-tunnelled Catheters
• Tunnelled Catheters

 

Global Central Venous Catheter Market, By Property

• Non-Antimicrobial Catheters
• Antimicrobial Catheters
• Others

 

Global Central Venous Catheter Market, By Composition

• Polyurethane
• Silicone
• Others

 

Global Central Venous Catheter Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. What is the current size of the global central venous catheter market?

The market was valued at USD 2.90 billion in 2024.

 

2. What is the projected market size by 2035?

 It is expected to reach USD 5.66 billion by 2035.

 

3. What is the CAGR for the forecast period?

The market is projected to grow at a CAGR of 6.27% from 2025 to 2035.

 

4. Which product type leads the market?

Tunnelled catheters held the largest share in 2024 due to their suitability for long-term use and lower complication risks.

 

5. Which property segment dominates?

Antimicrobial catheters dominated in 2024, driven by their ability to reduce infection risks in critical care.

 

6. What material has the highest revenue share?

Polyurethane led in 2024, valued for its flexibility, durability, and suitability for high-pressure applications.

 

7. Which region is expected to grow the fastest?

North America is poised for the fastest growth, fueled by advanced healthcare infrastructure and high chronic disease prevalence.